Alan Go to Prospective Studies
This is a "connection" page, showing publications Alan Go has written about Prospective Studies.
Connection Strength
2.406
-
Rationale and design of the pragmatic randomized trial of icosapent ethyl for high cardiovascular risk adults (MITIGATE). Am Heart J. 2021 05; 235:54-64.
Score: 0.147
-
Thromboprophylaxis for Patients with High-risk Atrial Fibrillation and Flutter Discharged from the Emergency Department. West J Emerg Med. 2018 Mar; 19(2):346-360.
Score: 0.120
-
Detection of paroxysmal atrial fibrillation by 30-day event monitoring in cryptogenic ischemic stroke: the Stroke and Monitoring for PAF in Real Time (SMART) Registry. Stroke. 2012 Oct; 43(10):2788-90.
Score: 0.082
-
Vascular risk factors and cognitive impairment in chronic kidney disease: the Chronic Renal Insufficiency Cohort (CRIC) study. Clin J Am Soc Nephrol. 2011 Feb; 6(2):248-56.
Score: 0.072
-
The assessment, serial evaluation, and subsequent sequelae of acute kidney injury (ASSESS-AKI) study: design and methods. BMC Nephrol. 2010 Aug 27; 11:22.
Score: 0.072
-
The net clinical benefit of warfarin anticoagulation in atrial fibrillation. Ann Intern Med. 2009 Sep 01; 151(5):297-305.
Score: 0.067
-
Proteomics of CKD progression in the chronic renal insufficiency cohort. Nat Commun. 2023 Oct 10; 14(1):6340.
Score: 0.044
-
Risk for Chronic Kidney Disease Progression After Acute Kidney Injury: Findings From the Chronic Renal Insufficiency Cohort Study. Ann Intern Med. 2023 07; 176(7):961-968.
Score: 0.044
-
The association between changes in echocardiography and risk of heart failure hospitalizations and death in adults with chronic kidney disease. Sci Rep. 2023 05 31; 13(1):8863.
Score: 0.043
-
Plasma Soluble Tumor Necrosis Factor Receptor Concentrations and Clinical Events After Hospitalization: Findings From the ASSESS-AKI and ARID Studies. Am J Kidney Dis. 2023 02; 81(2):190-200.
Score: 0.041
-
Change in ankle-brachial index and mortality among individuals with chronic kidney disease: findings from the Chronic Renal Insufficiency Cohort Study. Nephrol Dial Transplant. 2021 12 02; 36(12):2224-2231.
Score: 0.039
-
Sex Differences in Cardiovascular Outcomes in CKD: Findings From the CRIC Study. Am J Kidney Dis. 2021 08; 78(2):200-209.e1.
Score: 0.037
-
Association Between Kidney Clearance of Secretory Solutes and Cardiovascular Events: The Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2021 08; 78(2):226-235.e1.
Score: 0.037
-
Change in Cardiac Biomarkers and Risk of Incident Heart Failure and Atrial Fibrillation in CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2021 06; 77(6):907-919.
Score: 0.036
-
A prospective cohort study of acute kidney injury and kidney outcomes, cardiovascular events, and death. Kidney Int. 2021 02; 99(2):456-465.
Score: 0.036
-
Association of Cardiac Biomarkers With the Kansas City Cardiomyopathy Questionnaire in Patients With Chronic Kidney Disease Without Heart Failure. J Am Heart Assoc. 2020 07 07; 9(13):e014385.
Score: 0.035
-
Progression of retinopathy and incidence of cardiovascular disease: findings from the Chronic Renal Insufficiency Cohort Study. Br J Ophthalmol. 2021 02; 105(2):246-252.
Score: 0.035
-
Discontinuation rates of warfarin versus direct acting oral anticoagulants in US clinical practice: Results from Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II). Am Heart J. 2020 08; 226:85-93.
Score: 0.035
-
Association Between Early Recovery of Kidney Function After Acute Kidney Injury and Long-term Clinical Outcomes. JAMA Netw Open. 2020 04 01; 3(4):e202682.
Score: 0.035
-
Post-Acute Kidney Injury Proteinuria and Subsequent Kidney Disease Progression: The Assessment, Serial Evaluation, and Subsequent Sequelae in Acute Kidney Injury (ASSESS-AKI) Study. JAMA Intern Med. 2020 03 01; 180(3):402-410.
Score: 0.035
-
Cardiac Biomarkers and Risk of Incident Heart Failure in Chronic Kidney Disease: The CRIC (Chronic Renal Insufficiency Cohort) Study. J Am Heart Assoc. 2019 11 05; 8(21):e012336.
Score: 0.034
-
Single Measurements of Carboxy-Terminal Fibroblast Growth Factor 23 and Clinical Risk Prediction of Adverse Outcomes in CKD. Am J Kidney Dis. 2019 12; 74(6):771-781.
Score: 0.033
-
Cardiac Biomarkers and Risk of Atrial Fibrillation in Chronic Kidney Disease: The CRIC Study. J Am Heart Assoc. 2019 08 06; 8(15):e012200.
Score: 0.033
-
Impact of AKI on Urinary Protein Excretion: Analysis of Two Prospective Cohorts. J Am Soc Nephrol. 2019 07; 30(7):1271-1281.
Score: 0.033
-
Burden and Outcomes of Heart Failure Hospitalizations in Adults With Chronic Kidney Disease. J Am Coll Cardiol. 2019 06 04; 73(21):2691-2700.
Score: 0.033
-
Treatment of atrial fibrillation with concomitant coronary or peripheral artery disease: Results from the outcomes registry for better informed treatment of atrial fibrillation II. Am Heart J. 2019 07; 213:81-90.
Score: 0.033
-
Care Patterns and Outcomes in Atrial Fibrillation Patients With and Without Diabetes: ORBIT-AF Registry. J Am Coll Cardiol. 2017 Sep 12; 70(11):1325-1335.
Score: 0.029
-
Fibroblast Growth Factor 23 and Anemia in the Chronic Renal Insufficiency Cohort Study. Clin J Am Soc Nephrol. 2017 Nov 07; 12(11):1795-1803.
Score: 0.029
-
Blood Pressure and Risk of Cardiovascular Events in Patients on Chronic Hemodialysis: The CRIC Study (Chronic Renal Insufficiency Cohort). Hypertension. 2017 08; 70(2):435-443.
Score: 0.029
-
Urine Kidney Injury Biomarkers and Risks of Cardiovascular Disease Events and All-Cause Death: The CRIC Study. Clin J Am Soc Nephrol. 2017 May 08; 12(5):761-771.
Score: 0.028
-
Loss of executive function after dialysis initiation in adults with chronic kidney disease. Kidney Int. 2017 04; 91(4):948-953.
Score: 0.028
-
Influence of Kidney Function Estimation Methods on Eligibility for Edoxaban Population Impact of the US Food and Drug Administration's Approach for Its Product Labeling. Circulation. 2016 10 11; 134(15):1122-1124.
Score: 0.027
-
Association of Fibroblast Growth Factor 23 With Atrial Fibrillation in Chronic Kidney Disease, From the Chronic Renal Insufficiency Cohort Study. JAMA Cardiol. 2016 Aug 01; 1(5):548-56.
Score: 0.027
-
Race/Ethnicity and Cardiovascular Outcomes in Adults With CKD: Findings From the CRIC (Chronic Renal Insufficiency Cohort) and Hispanic CRIC Studies. Am J Kidney Dis. 2016 Oct; 68(4):545-553.
Score: 0.027
-
CKD Progression and Mortality among Hispanics and Non-Hispanics. J Am Soc Nephrol. 2016 Nov; 27(11):3488-3497.
Score: 0.027
-
Atrial Fibrillation and Risk of ESRD in Adults with CKD. Clin J Am Soc Nephrol. 2016 07 07; 11(7):1189-96.
Score: 0.026
-
Cognitive Impairment and Progression of CKD. Am J Kidney Dis. 2016 Jul; 68(1):77-83.
Score: 0.026
-
Anemia and risk for cognitive decline in chronic kidney disease. BMC Nephrol. 2016 Jan 28; 17:13.
Score: 0.026
-
Sinus Node Dysfunction Is Associated With Higher Symptom Burden and Increased Comorbid Illness: Results From the ORBIT-AF Registry. Clin Cardiol. 2016 Feb; 39(2):119-25.
Score: 0.026
-
Prevalence and Correlates of CKD in Hispanics/Latinos in the United States. Clin J Am Soc Nephrol. 2015 Oct 07; 10(10):1757-66.
Score: 0.025
-
A prospective investigation of cell dose in single-unit umbilical cord blood transplantation for adults with high-risk hematologic malignancies. Bone Marrow Transplant. 2015 Dec; 50(12):1519-25.
Score: 0.025
-
Electrocardiographic Measures and Prediction of Cardiovascular and Noncardiovascular Death in CKD. J Am Soc Nephrol. 2016 Feb; 27(2):559-69.
Score: 0.025
-
Digoxin Use and Subsequent Outcomes Among Patients in a Contemporary Atrial Fibrillation Cohort. J Am Coll Cardiol. 2015 Jun 30; 65(25):2691-8.
Score: 0.025
-
Association Between Atrial Fibrillation Symptoms, Quality of Life, and Patient Outcomes: Results From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). Circ Cardiovasc Qual Outcomes. 2015 Jul; 8(4):393-402.
Score: 0.025
-
Kansas City Cardiomyopathy Questionnaire Score Is Associated With Incident Heart Failure Hospitalization in Patients With Chronic Kidney Disease Without Previously Diagnosed Heart Failure: Chronic Renal Insufficiency Cohort Study. Circ Heart Fail. 2015 Jul; 8(4):702-8.
Score: 0.025
-
Phosphate, fibroblast growth factor 23 and retinopathy in chronic kidney disease: the Chronic Renal Insufficiency Cohort Study. Nephrol Dial Transplant. 2015 Sep; 30(9):1534-41.
Score: 0.025
-
Serum Fractalkine (CX3CL1) and Cardiovascular Outcomes and Diabetes: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2015 Aug; 66(2):266-73.
Score: 0.025
-
Association between chronic kidney disease progression and cardiovascular disease: results from the CRIC Study. Am J Nephrol. 2014; 40(5):399-407.
Score: 0.024
-
Blood pressure and risk of all-cause mortality in advanced chronic kidney disease and hemodialysis: the chronic renal insufficiency cohort study. Hypertension. 2015 Jan; 65(1):93-100.
Score: 0.024
-
Higher levels of cystatin C are associated with worse cognitive function in older adults with chronic kidney disease: the chronic renal insufficiency cohort cognitive study. J Am Geriatr Soc. 2014 Sep; 62(9):1623-9.
Score: 0.024
-
Arterial stiffness, central pressures, and incident hospitalized heart failure in the chronic renal insufficiency cohort study. Circ Heart Fail. 2014 Sep; 7(5):709-16.
Score: 0.023
-
Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II: rationale and design of the ORBIT-AF II registry. Am Heart J. 2014 Aug; 168(2):160-7.
Score: 0.023
-
Lack of concordance between empirical scores and physician assessments of stroke and bleeding risk in atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry. Circulation. 2014 May 20; 129(20):2005-12.
Score: 0.023
-
Drivers of hospitalization for patients with atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). Am Heart J. 2014 May; 167(5):735-42.e2.
Score: 0.023
-
Higher plasma CXCL12 levels predict incident myocardial infarction and death in chronic kidney disease: findings from the Chronic Renal Insufficiency Cohort study. Eur Heart J. 2014 Aug 14; 35(31):2115-22.
Score: 0.022
-
Association of kidney disease outcomes with risk factors for CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) study. Am J Kidney Dis. 2014 Feb; 63(2):236-43.
Score: 0.022
-
Physical performance and frailty in chronic kidney disease. Am J Nephrol. 2013; 38(4):307-15.
Score: 0.022
-
Use and associated risks of concomitant aspirin therapy with oral anticoagulation in patients with atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Registry. Circulation. 2013 Aug 13; 128(7):721-8.
Score: 0.022
-
Risks and benefits of anticoagulation in atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry. Circ Cardiovasc Qual Outcomes. 2013 Jul; 6(4):461-9.
Score: 0.022
-
Candidate gene association study of coronary artery calcification in chronic kidney disease: findings from the CRIC study (Chronic Renal Insufficiency Cohort). J Am Coll Cardiol. 2013 Aug 27; 62(9):789-98.
Score: 0.022
-
A longitudinal study of left ventricular function and structure from CKD to ESRD: the CRIC study. Clin J Am Soc Nephrol. 2013 Mar; 8(3):355-62.
Score: 0.021
-
Recruitment of Hispanics into an observational study of chronic kidney disease: the Hispanic Chronic Renal Insufficiency Cohort Study experience. Contemp Clin Trials. 2012 Nov; 33(6):1238-44.
Score: 0.020
-
Ethnic differences in the development of albuminuria: the DISTANCE study. Am J Manag Care. 2011 Nov; 17(11):737-45.
Score: 0.019
-
FGF23 induces left ventricular hypertrophy. J Clin Invest. 2011 Nov; 121(11):4393-408.
Score: 0.019
-
Outcomes registry for better informed treatment of atrial fibrillation: rationale and design of ORBIT-AF. Am Heart J. 2011 Oct; 162(4):606-612.e1.
Score: 0.019
-
CKD in Hispanics: Baseline characteristics from the CRIC (Chronic Renal Insufficiency Cohort) and Hispanic-CRIC Studies. Am J Kidney Dis. 2011 Aug; 58(2):214-27.
Score: 0.019
-
Detection of atrial fibrillation after stroke and the risk of recurrent stroke. J Stroke Cerebrovasc Dis. 2012 Nov; 21(8):726-31.
Score: 0.019
-
Chronic kidney disease and prevalent atrial fibrillation: the Chronic Renal Insufficiency Cohort (CRIC). Am Heart J. 2010 Jun; 159(6):1102-7.
Score: 0.018
-
Chronic Renal Insufficiency Cohort (CRIC) Study: baseline characteristics and associations with kidney function. Clin J Am Soc Nephrol. 2009 Aug; 4(8):1302-11.
Score: 0.016
-
Insulin resistance independently predicts the progression of coronary artery calcification. Am Heart J. 2009 May; 157(5):939-45.
Score: 0.016
-
Incidental findings on cardiac multidetector row computed tomography among healthy older adults: prevalence and clinical correlates. Arch Intern Med. 2008 Apr 14; 168(7):756-61.
Score: 0.015
-
Common polymorphisms of ALOX5 and ALOX5AP and risk of coronary artery disease. Hum Genet. 2008 May; 123(4):399-408.
Score: 0.015
-
Glycemic response to newly initiated diabetes therapies. Am J Manag Care. 2007 Nov; 13(11):598-606.
Score: 0.015
-
Effects of short daily versus conventional hemodialysis on left ventricular hypertrophy and inflammatory markers: a prospective, controlled study. J Am Soc Nephrol. 2005 Sep; 16(9):2778-88.
Score: 0.013
-
Hormone therapy and the risk of stroke after acute myocardial infarction in postmenopausal women. J Am Coll Cardiol. 2001 Nov 01; 38(5):1297-301.
Score: 0.010
-
Treatment and outcomes of left bundle-branch block patients with myocardial infarction who present without chest pain. National Registry of Myocardial Infarction 2 Investigators. J Am Coll Cardiol. 2000 Sep; 36(3):706-12.
Score: 0.009